AMTI RSI Chart
Last 7 days
-16.1%
Last 30 days
62.5%
Last 90 days
65.6%
Trailing 12 Months
-40.2%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 27, 2023 | vandevender aaron | back to issuer | - | - | -212,659 | - |
Dec 27, 2023 | cross shawn | back to issuer | - | - | -545,499 | ceo & chair of the board |
Dec 27, 2023 | mahmood tahir ph.d. | back to issuer | - | - | -3,208,310 | - |
Dec 27, 2023 | hants brandon | back to issuer | - | - | -301,225 | cfo |
Dec 27, 2023 | mahmood tahir ph.d. | back to issuer | - | - | -391,693 | - |
Dec 27, 2023 | epiq capital group, llc | sold | - | - | -8,337,520 | - |
Dec 27, 2023 | mahmood tahir ph.d. | back to issuer | - | - | -484,738 | - |
Nov 22, 2023 | cross shawn | sold | -18,116 | 0.1635 | -110,802 | ceo & chair of the board |
Nov 22, 2023 | hants brandon | sold | -10,054 | 0.1635 | -61,494 | cfo |
Nov 22, 2023 | mahmood tahir ph.d. | sold | -46,784 | 0.1634 | -286,320 | - |
Which funds bought or sold AMTI recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 13, 2024 | XTX Topco Ltd | sold off | -100 | -4,735 | - | -% |
May 06, 2024 | Advisory Services Network, LLC | sold off | -100 | -132 | - | -% |
Jan 31, 2023 | Burleson & Company, LLC | reduced | -74.00 | -31,045 | 3,955 | -% |
May 16, 2022 | Amalgamated Financial Corp. | new | - | 31,000 | 31,000 | -% |
May 16, 2022 | Parametric Portfolio Associates LLC | reduced | -41.09 | -212,000 | 99,000 | -% |
Feb 15, 2022 | NEXT Financial Group, Inc | unchanged | - | -1,000 | - | -% |
Nov 15, 2021 | Marshall Wace North America L.P. | added | 28.57 | -81,000 | 216,000 | -% |
Oct 07, 2021 | Berman Capital Advisors, LLC | new | - | 1,000 | 1,000 | -% |
Unveiling Applied Molecular Transport Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to Applied Molecular Transport Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Applied Molecular Transport Inc. News
Balance Sheet | ||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Assets | -19.8% | 20.00 | 25.00 | 83.00 | 107 | 125 | 147 | 182 | 214 | 207 | 224 | 126 | 140 | 158 | 173 | 39.00 |
Current Assets | -19.3% | 19.00 | 23.00 | 46.00 | 64.00 | 80.00 | 101 | 133 | 167 | 188 | 206 | 112 | 132 | 149 | 166 | 33.00 |
Cash Equivalents | -19.4% | 18.00 | 22.00 | 42.00 | 61.00 | 76.00 | 96.00 | 126 | 161 | 152 | 159 | 26.00 | 6.00 | 11.00 | 23.00 | 13.00 |
Net PPE | -20.5% | 0.00 | 0.00 | 3.00 | 8.00 | 9.00 | 9.00 | 9.00 | 7.00 | 6.00 | 7.00 | 7.00 | 8.00 | 8.00 | 7.00 | 4.00 |
Liabilities | -12.5% | 4.00 | 4.00 | 47.00 | 47.00 | 46.00 | 50.00 | 54.00 | 50.00 | 20.00 | 16.00 | 13.00 | 9.00 | 9.00 | 8.00 | 5.00 |
Current Liabilities | -1.1% | 4.00 | 4.00 | 17.00 | 15.00 | 14.00 | 16.00 | 18.00 | 14.00 | 10.00 | 8.00 | 9.00 | 8.00 | 8.00 | 7.00 | 4.00 |
Shareholder's Equity | -21.3% | 16.00 | 21.00 | 36.00 | 61.00 | 78.00 | 98.00 | 128 | 164 | 188 | 208 | 114 | 132 | 149 | 165 | - |
Retained Earnings | -1.7% | -418 | -411 | -393 | -365 | -343 | -318 | -282 | -239 | -209 | -183 | -159 | -139 | -120 | -103 | -72.79 |
Additional Paid-In Capital | 0.6% | 434 | 432 | 430 | 427 | 422 | 416 | 410 | 403 | 397 | 392 | 273 | 271 | 269 | 269 | 1.00 |
Shares Outstanding | 3.7% | 41.00 | 39.00 | 39.00 | 39.00 | 39.00 | 39.00 | 39.00 | 39.00 | 37.00 | 38.00 | 35.00 | 23.00 | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 |
Cashflow From Operations | 79.6% | -4,399 | -21,523 | -19,298 | -14,816 | -19,564 | -28,389 | -31,131 | -22,480 | -17,040 | -22,141 | -20,948 | -16,705 | -13,581 | -14,897 | -13,711 | - | - | - |
Share Based Compensation | 38.5% | 2,531 | 1,828 | 3,223 | 4,962 | 5,842 | 5,590 | 6,773 | 5,477 | 4,937 | 4,333 | 1,951 | 1,078 | 762 | 659 | 557 | - | - | - |
Cashflow From Investing | -96.9% | 45.00 | 1,471 | -7.00 | -6.00 | -223 | -2,406 | -1,517 | 29,112 | 9,608 | 41,565 | 41,921 | 10,804 | 2,246 | -130,944 | 8,608 | - | - | - |
Cashflow From Financing | 100.0% | - | -178 | -69.00 | -53.00 | -132 | 145 | -693 | 734 | 432 | 113,829 | 303 | 430 | -752 | 163,275 | -1,657 | - | - | - |
Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Operating expenses: | ||||
Research and development | $ 250 | $ 18,233 | $ 15,796 | $ 72,273 |
General and administrative | 7,007 | 7,281 | 20,804 | 28,052 |
Restructuring, impairment, and related charges | (40) | 12 | 16,832 | 3,799 |
Total operating expenses | 7,217 | 25,526 | 53,432 | 104,124 |
Loss from operations | (7,217) | (25,526) | (53,432) | (104,124) |
Interest income, net | 283 | 321 | 1,281 | 393 |
Other income (expense), net | (3) | (1) | (36) | 5 |
Net loss | $ (6,937) | $ (25,206) | $ (52,187) | $ (103,726) |
Net loss per share, basic (in dollars per share) | $ (0.17) | $ (0.65) | $ (1.32) | $ (2.68) |
Net loss per share, diluted (in dollars per share) | $ (0.17) | $ (0.65) | $ (1.32) | $ (2.68) |
Weighted-average shares of common stock outstanding, basic (in shares) | 39,751,028 | 38,914,570 | 39,426,218 | 38,769,226 |
Weighted-average shares of common stock outstanding, diluted (in shares) | 39,751,028 | 38,914,570 | 39,426,218 | 38,769,226 |
Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 18,103 | $ 61,145 |
Prepaid expenses | 457 | 2,688 |
Other current assets | 259 | 186 |
Total current assets | 18,819 | 64,019 |
Property and equipment, net | 31 | 8,183 |
Operating lease right-of-use assets | 1,165 | 33,222 |
Finance lease right-of-use assets | 0 | 584 |
Restricted cash | 0 | 916 |
Other assets | 0 | 522 |
Total assets | 20,015 | 107,446 |
Current liabilities: | ||
Accounts payable | 161 | 1,583 |
Accrued expenses | 2,261 | 8,660 |
Lease liabilities, operating lease - current | 1,353 | 4,639 |
Lease liabilities, finance lease - current | 0 | 205 |
Total current liabilities | 3,775 | 15,087 |
Lease liabilities, operating lease | 0 | 31,228 |
Lease liabilities, finance lease | 0 | 49 |
Other liabilities | 0 | 244 |
Total liabilities | 3,775 | 46,608 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value: 50,000,000 shares authorized; none issued and outstanding | 0 | 0 |
Common stock, $0.0001 par value, 450,000,000 shares authorized; 40,893,507 and 39,181,801 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | 4 | 4 |
Additional paid-in capital | 434,393 | 426,804 |
Accumulated deficit | (418,157) | (365,970) |
Total stockholders’ equity | 16,240 | 60,838 |
Total liabilities and stockholders’ equity | $ 20,015 | $ 107,446 |